Suppression of alveolar macrophage apoptosis prolongs survival of rats and mice with Pneumocystis pneumonia

Journal of Immunology

Volumn 176, Issue 11, 2006, Pages 6443-6453

  Lasbury, Mark E ^a   Durant, Pamela J ^a   Ray, Chad A ^a   Tschang, Dennis ^a   Schwendener, Reto ^b   Lee, Chao Hung ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 10; CASPASE 8; CASPASE 8 INHIBITOR; CASPASE 9; CASPASE 9 INHIBITOR; DEXAMETHASONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPHENOTYPING; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PNEUMOCYSTIS; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRIORITY JOURNAL; RAT; SURVIVAL;

EID: 33646882912     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.11.6443     Document Type: Article

References (61)

1. Furuta, T., K. Ueda, S. Kyuma, and K. Fujiwara. 1984. Effect of T-cell transfer on Pneumocystis carinii infection in nude mice. Jpn. J. Exp. Med. 54: 57-64.
2. Shellito, J., V. V. Suzara, W. Blumenfeld, J. M. Beck, H. J. Steger, and T. H. Ermak. 1990. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J. Clin. Invest. 85: 1686-1693.
3. Wallace, J. M., N. I. Hansen, L. Lavange, J. Glassroth, B. L. Browdy, M. J. Rosen, P. A. Kvale, B. T. Mangura, L. B. Reichman, and P. C. Hopewell. 1997. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort: pulmonary complications of HIV infection study group. Am. J. Respir. Crit. Care Med. 155: 72-80.
4. Walzer, P. D., V. Schnelle, D. Armstrong, and P. P. Rosen. 1977. Nude mouse: a new experimental model of Pneumocystis carinii infection. Science 197: 177-179.
5. Theus, S. A., D. W. Sullivan, P. D. Walzer, and A. G. Smulian. 1994. Cellular responses to a 55-kilodalton recombinant Pneumocystis carinii antigen. Infect. Immun. 62: 3479-3484.
6. Beck, J. M., H. D. Liggitt, E. N. Brunette, H. J. Fuchs, J. E. Shellito, and R. J. Debs. 1991. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect. Immun. 59: 3859-3862.
7. + T cells. J. Immunol. 162: 2890-2894.
8. Shear, H. L., G. Valladares, and M. A. Narachi. 1990. Enhanced treatment of Pneumocystis carinii pneumonia in rats with interferon-γ and reduced doses of trimethoprim/sulfamethoxazole. J. Acquir. Immune Def. Syndr. 3: 943-948.
9. Garvy, B. A., F. Gigliotti, and A. G. Harmsen. 1997. Neutralization of interferon-γ exacerbates Pneumocystis-driven interstitial pneumonitis after bone marrow transplantation in mice. J. Clin. Invest. 99: 1637-1644.
10. + lymphocytes in host defense against Pneumocystis carinii in mice. J. Lab. Clin. Med. 128: 477-487.
11. Wright, T. W., F. Gigliotti, J. N. Finkelstein, J. T. McBride, C. L. An, and A. G. Harmsen. 1999. Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J. Clin. Invest. 104: 1307-1317.
12. Wright, T. W., R. H. Notter, Z. Wang, A. G. Harmsen, and F. Gigliotti. 2001. Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia. Infect. Immun. 69: 758-764.
13. Pifer, L. L., W. T. Hughes, D. Stagno, and D. Woods. 1978. Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics 61: 35-41.
14. Marcotte, H., D. Levesque, K. Delanay, A. Bourgeault, R. de la Durantaye, S. Brochu, and M. C. Lavoie. 1996. Pneumocystis carinii infection in transgenic B cell-deficient mice. J. Infect. Dis. 173: 1034-1037.
15. Garvy, B. A., J. A. Wiley, F. Gigliotti, and A. G. Harmsen. 1997. Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses. Infect. Immun. 65: 5052-5056.
16. Gigliotti, F., and W. T. Hughes. 1988. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J. Clin. Invest. 81: 1666-1668.
17. Gigliotti, F., C. G. Haidaris, T. W. Wright, and A. G. Harmsen. 2002. Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia. Infect. Immun. 70: 1069-1074.
18. Harmsen, A. G., W. Chen, and F. Gigliotti. 1995. Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice. Infect. Immun. 63: 2391-2395.
19. Lund, F. E., K. Schuer, M. Hollifield, T. D. Randall, and B. A. Garvy. 2003. Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P. carinii-specific antibody. J. Immunol. 171: 1423-1430.
20. Koziel, H., X. Li, M. Y. Armstrong, F. F. Richards, and R. M. Rose. 2000. Alveolar macrophages from human immunodeficiency virus-infected persons demonstrate impaired oxidative burst response to Pneumocystis carinii in vitro. Am. J. Respir. Cell Mol. Biol. 23: 452-459.
21. Steele, C., L. Marrero, S. Swain, A. G. Harmsen, M. Zheng, G. D. Brown, S. Gordon, J. E. Shellito, and J. K. Kolls. 2003. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 β-glucan receptor. J. Exp. Med. 198: 1677-1688.
22. Chen, W., E. A. Havell, L. L. Moldawer, K. W. McIntyre, R. A. Chizzonite, and A. G. Harmsen. 1992. Interleukin 1: an important mediator of host resistance against Pneumocystis carinii. J. Exp. Med. 176: 713-718.
23. Chen, W., J. W. Mills, and A. G. Harmsen. 1992. Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of host inflammatory responses. Int. J. Exp. Pathol. 73: 709-720.
24. Chen, W., E. A. Havel, F. Gigliotti, and A. G. Harmsen. 1993. Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance an inflammatory response. Infect. Immun. 61: 97-102.
25. Hoffman, O. A., J. E. Standing, and A. H. Limper. 1993. Pneumocystis carinii stimulates tumor necrosis factor-α release from alveolar macrophages through a β-glucan-mediated mechanism. J. Immunol. 150: 3932-3940.
26. Krishnan, V. L., A. Meager, D. M. Mitchell, and A. J. Pinching. 1990. Alveolar macrophages in AIDS patients: increased spontaneous tumor necrosis factor-α production in Pneumocystis carinii pneumonia. Clin. Exp. Immunol. 80: 156-160.
27. Mandujano, J. F., N. B. D'Souza, S. Nelson, W. R. Summer, R. C. Beckerman, and J. E. Shellito. 1995. Granulocyte-macrophage colony stimulating factor in Pneumocystis carinii pneumonia in mice. Am. J. Respir. Crit. Care Med. 151: 1233-1238.
28. Ezekowitz, R. A. B., D. J. Williams, H. Koziel, M. Y. Armstrong, A. Warner, F. F. Richards, and R. M. Rose. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 351: 155-158.
29. Limper, A. H., J. S. Hoyte, and J. E. Standing. 1997. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J. Clin. Invest. 99: 2110-2117.
30. Masur, H., and T. C. Jones. 1978. The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J. Exp. Med. 147: 157-170.
31. Hidalgo, H. A., R. J. Helmke, V. F. German, and J. A. Mangos. 1992. Pneumocystis carinii induces an oxidative burst in alveolar macrophages. Infect. Immun. 60: 1-7.
32. Koziel, H., Q. Eichbaum, B. A. Kruskal, P. Pinkston, R. A. Rogers, M. Y. Armstrong, F. F. Richards, R. M. Rose, and R. A. Ezekowitz. 1998. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor down regulation. J. Clin. Invest. 102: 1332-1344.
33. Lasbury, M. E., P. Lin, D. Tschang, P. J. Durant, and C. H. Lee. 2004. Effect of bronchoalveolar lavage fluid from Pneumocystis carom-infected hosts on phagocytic activity of alveolar macrophages. Infect. Immun. 72: 2140-2147.
34. Lasbury, M. E., P. J. Durant, and C. H. Lee. 2003. Inducible nitric oxide synthase expression in Pneumocystis carinii pneumonia. J. Eukaryotic Microbiol. 50(Suppl.): 634-635.
35. Simonpoli, A. M., P. Rajagopalan-Levasseur, M. Brun-Pascard, G. Bertrand, M. A. Pocidalo, and P. M. Girard. 1996. Influence of Pneumocystis carinii on nitrite production by rat alveolar macrophages. J. Eukaryotic Microbiol. 43: 400-403.
36. Fleury, J., E. Escudier, M.-J. Pochelle, C. Carre, and J. F. Bernaudin. 1985. Cell population obtained by bronchoalveolar lavage in Pneumocystis carinii pneumonias. Acta Cytol. 29: 721-726.
37. Fleury-Feith, J., J. T. Van Nhieu, C. Picard, E. Escudier, and J. F. Bernaudin. 1989. Bronchoalveolar lavage eosinophilia associated with Pneumocystis carinii pneumonitis in AIDS patients: comparative study with non-AIDS patients. Chest 95: 1198-1201.
38. Young, J. A., J. M. Hopkin, and W. P. Cuthbertson. 1984. Pulmonary infiltrates in immunocompromised patients: diagnosis by cytological examination of bronchoalveolar lavage fluid. J. Clin. Pathol. 37: 390-397.
39. Young, J. A., J. W. Stone, R. J. S. McGonigle, D. Adu, and J. Michael. 1986. Diagnosing Pneumocystis carinii pneumonia by cytological examination of bronchoalveolar lavage fluid: a report of 15 cases. J. Clin. Pathol. 39: 945-949.
40. Sadaghdar, H., Z.-B. Huang, and E. Eden. 1992. Correlation of bronchoalveolar lavage findings to severity of Pneumocystis carinii pneumonia in AIDS: evidence for the development of high-permeability pulmonary edema. Chest 102: 63-69.
41. Lasbury, M. E., P. J. Durant, M. S. Bartlett, J. W. Smith, and C. H. Lee. 2003. Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery. Clin. Diagn. Lab. Immunol. 10: 293-302.
42. + antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes. Clin. Diagn. Lab. Immunol. 1: 511-516.
43. Bartlett, M. S., J. A. Fishman, M. M. Durkin, S. F. Queener, and J. W. Smith. 1988. New rat model of Pneumocystis carinii infection. J. Clin. Microbiol. 26: 1100-1102.
44. Huston, C. D., E. R. Houpt, B. J. Mann, C. S. Hahn, and W. A. Petri, Jr. 2000. Caspase 3-dependent killing of host cells by the parasite Entamoeba histolytica. Cell. Microbiol. 2: 617-625.
45. Zaks, T. Z., D. B. Chappell, S. A. Rosenberg, and N. P. Restifo. 1999. Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition. J. Immunol. 162: 3273-3279.
46. Fleit, S. A., H. B. Fleit, and S. Zolla-Pazner. 1984. Culture and recovery of macrophages and cell lines from tissue culture-treated and -untreated plastic dishes. J. Immunol. Methods 68: 119-129.
47. Chin, K., S. Merali, M. M. Shaw, M. S. Bartlett, and A. B. Clarkson, Jr. 1996. Subpopulations of Pneumocystis carinii separated by a Percoll gradient. J. Eukaryotic Microbiol. 43: 53s.
48. Kaneshiro, E. S., Y. P. Wu, and M. T. Cushion. 1991. Assays for testing Pneumocystis carinii viability. J. Parasitol. 38: 85s-87s.
49. Lasbury, M. E., X. Tang, P. J. Durant, and C. H. Lee. 2003. Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts. Infect. Immun. 71: 4943-4952.
50. Roscic-Mrkic, B., R. A. Schwendener, B. Odermatt, A. Zuniga, J. Pavlovic, M. A. Billeter, and R. Cattaneo. 2001. Roles of macrophages in measles virus infection of genetically modified mice. J. Virol. 75: 3343-3351.
51. Jacysyn, J. F., M. Conde-Moscatelli, C. R. C. Barrichello, U. R. Silva, M. S. Macedo, and G. P. Amarante-Mendes. 2002. Thymic epithelial cells mediate a Bcl-2-independent protection of single-positive thymocytes from dexamethasone-induced apoptosis. Exp. Cell Res. 272: 119-126.
52. Thompson, E. B. 1999. Mechanisms of T-cell apoptosis induced by glucocorticoids. Trends Endocrinol. Metab. 10: 353-358.
53. Dockrell, D. H., H. M. Marriott, L. R. Prince, V. C. Ridger, P. G. Ince, P. G. Hellewell, and M. K. B. Whyte. 2003. Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection. J. Immunol. 171: 5380-5388.
54. Shah, N., R. J. Asch, A. S. Lysholm, and T. W. LeBien. 2004. Enhancement of stress-induced apoptosis in B-lineage cells by caspase-9 inhibitor. Blood. 104: 2873-2878.
55. Keane, J., M. K. Balcewicz-Sablinska, H. G. Remold, G. L. Chupp, B. B. Meek, M. J. Fenton, and H. Kornfeld, H. 1997. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65: 298-304.
56. Balcewicz-Sablinska, M. K., J. Keane, H. Kornfeld, and H. G. Remold. 1998. Pathogenic Mycobacterium tuberculosis evades apoptosis of macrophages by release of TNF-R2, resulting in inactivation of TNF-α. J. Immunol. 161: 2636-2641.
57. Danelishvili, L., J. McGarvey, Y. J. Li, and L. E. Bermudez. 2003. Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells. Cell. Microbiol. 5: 649-660.
58. Mele, R., M. A. Gomez Morales, F. Tosini, and E. Pozio. 2004. Cryptosporidium parvum at different developmental stages modulates host cell apoptosis in vivo. Infect. Immun. 72: 6061-6067.
59. Koterski, J. F., M. Nahvi, M. M. Venkatesan, and B. Haimovich. 2005. Virulent Shigella flexneri causes damage to mitochondria and triggers necrosis in infected human monocyte-derived macrophages. Infect. Immun. 73: 504-513.
60. Chaturvedi, R., Y. Cheng, M. Asim, F. I. Bussiere, H. Xu, A. P. Gobert, A. Hacker, R. A. Casero, Jr., and K. T. Wilson. 2004. Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization. J. Biol. Chem. 279: 40161-40173.
61. Menaker, R. J., P. J. M. Ceponis, and N. L. Jones. 2004. Helicobacter pylori induces apoptosis of macrophages 1 association with alterations in the mitochondrial pathway. Infect. Immun. 72: 2889-2898.